General Electric's Acquisition of Amersham PLC Case Solution
In September 2003, Jeffrey Immelt, CEO of General Electric, must assess a final suggestion for GE to get Amersham plc, the top manufacturer of contrast agents. The case allows the valuation of Amersham based on recent trading history, similar transactions, and peer companies. On close examination, the business's IP position is not stronger than it seems, given recent patents filed by opponents. The economical impact of these IP challenges may be examined in the instance Visipaque, of the firm's top product, for which cash flows are given by the case. A crucial lesson underscores the value of due diligence research on the IP standing of a company.
This is just an excerpt. This case is about ORGANIZATIONAL DEVELOPMENT
PUBLICATION DATE: November 03, 2004